COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,233 Articles (22,733 medRxiv, 8,500 bioRxiv)

Most recent first Previous |  Page 427: Articles 4261-4270  | Next

Adsorption of respiratory syncytial virus (RSV), rhinovirus, SARS-CoV-2, and F+ bacteriophage MS2 RNA onto wastewater solids from raw wastewater
Roldan-Hernandez, L., Boehm, A.
10.1101/2023.05.04.539429 — Posted: 2023-05-05
UDCA May Promote COVID-19 Recovery: A Cohort Study with AI-Aided Analysis
Yu, Y., Yu, G., Han, L.-Y., Li, J., Zhang, Z.-L., Liu, T.-S., Li, M.-F., Zhan, D.-C., Tang, S.-Q., Zhou, Z.-H., Wang, G.-J.
10.1101/2023.05.02.23289410 — Posted: 2023-05-04
What happened to health labour markets during COVID-19? Insights from a survey of medical doctors in Brazil
de Oliveira, B. L. C. A., Scheffer, M. C., Cassenote, A. J. F., Russo, G.
10.1101/2023.05.03.23289458 — Posted: 2023-05-04
Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3C
Bhatia, A., Preiss, A. J., Xiao, X., Brannock, M. D., Alexander, G. C., Chew, R. F., Fitzgerald, M., Hill, E., Kelly, E. P., Mehta, H. B., Madlock-Brown, C., Wilkins, K. J., Chute, C. G., Haendel, M., Moffitt, R., Pfaff, E. R., The N3C Consortium
10.1101/2023.05.03.23289084 — Posted: 2023-05-04
Researching COVID to enhance recovery (RECOVER) autopsy study protocol: Rationale, objectives, and design
Troxel, A. B., Bind, M.-A. C., Flotte, T. J., Cordon-Cardo, C., Decker, L. A., Finn, A. V., Padera, R. F., Reichard, R. R., Stone, J. R., Adolphi, N. L., Casimero, F. V. C., Crary, J. F., Elifritz, J., Faustin, A., Ghosh, S. K. B., Krausert, A., Martinez-Lage, M., Melamed, J., Mitchell, R. A., Sampson, B. A., Seifert, A. C., Simsir, A., Adams, C., Haasnoot, S., Hafner, S., Siciliano, M. A., Vallejos, B., Del Boccio, P., Lamendola-Essel, M. F., Young, C. E., Kewlani, D., Akinbo, P. A., Parent, B., Chung, A., Cato, T. C., Mudumbi, P. C., Esquenazi-Karonika, S., Wood, M. J., Chan, J., Monteiro, J
10.1101/2023.04.27.23289234 — Posted: 2023-05-04
Integrated NMR and MS analysis of plasma metabolome reveals major changes in inflammatory markers, one-carbon, lipid, and amino acid metabolism in severe and fatal COVID-19 subjects
Gama-Almeida, M. C., Teixeira, L., Hottz, E. D., Ivens, P., Ribeiro, H., Pinto, G. D., Garrett, R., Torres, A. G., Carneiro, T. I., Barbalho, B. d. O., Ludwig, C., Struchiner, C. J., Assuncao-Miranda, I., Valente, A. P. C., Bozza, F. A., Bozza, P. T., dos Santos, G. C., El-Bacha, T.
10.1101/2023.04.19.23288802 — Posted: 2023-05-04
Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccine
Wang, Q., Guo, Y., Tam, A. R., Valdez, R., Gordon, A., Lihong, L., Ho, D. D.
10.1101/2023.05.03.539268 — Posted: 2023-05-04
Probing Conformational Landscapes of Binding and Allostery in the SARS-CoV-2 Omicron Variant Complexes Using Microsecond Atomistic Simulations and Perturbation-Based Profiling Approaches: Hidden Role of Omicron Mutations as Modulators of Allosteric Signaling and Epistatic Relationships
Verkhivker, G., Alshahrani, M., Gupta, G., Xiao, S., Tao, P.
10.1101/2023.05.03.539337 — Posted: 2023-05-04
A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters
Ying, B., Darling, T. L., Desai, P., Liang, C.-Y., Dmitriev, I. P., Soudani, N., Bricker, T. L., Kashentseva, E. A., Harastani, H. H., Schmidt, A. G., Curiel, D. T., Boon, A. C. M., Diamond, M. S.
10.1101/2023.05.04.539332 — Posted: 2023-05-04
Broad-Spectrum Heavily Mutated Monoclonal Antibody Isolated from COVID-19 Convalescent Vaccinee with Capacity to Neutralize SARS-CoV2 Variants Ranging from B.1 to BQ.1.1
Choudhary, A. K., Calianese, D., Honnen, W., Kolloli, A., Dikdan, R. J., Jaijyan, D., Song, G., Capozzola, T., Akkaraju, V., Mattappallil, A., Rosania, A., Khan, S., Lerman, M., Afzal, N., Subbian, S., Chou, T. C., Andrabi, R., Burton, D., Pinter, A.
10.1101/2023.05.04.539267 — Posted: 2023-05-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).